Certified by Founder Lodge
ReNAgade Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $300,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 25 ,2023 | Series A | $300,000,000 |
F2 Venture Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
StretchSense | $2,300,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
